<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7182600\results\search\disease\results.xml">
  <result pre="doi: 10.1111/irv.12713IRV12713 : Original Article: Original Articles Antigenic variants of" exact="influenza" post="B viruses isolated in Japan during the 2017�?2018 and"/>
  <result pre="B viruses isolated in Japan during the 2017�?2018 and 2018�?2019" exact="influenza" post="seasons KATO�?MIYASHITA et al. Kato�?MiyashitaSarihttps://orcid.org/0000-0003-0233-88171Sakai�?TagawaYuko1YamashitaMakoto1Iwatsuki�?HorimotoKiyokohttps://orcid.org/0000-0002-8266-020X1ItoMutsumi1TokitaAkifumi23HagiwaraHaruhisa34IzumidaNaomi35NishinoTamon36WadaNoriyuki37KogaMichikohttps://orcid.org/0000-0002-3122-97358AdachiEisukehttps://orcid.org/0000-0002-1623-873X9JubishiDaisuke110YotsuyanagiHiroshihttps://orcid.org/0000-0001-7882-52629KawaokaYoshihirohttps://orcid.org/0000-0001-5061-829611112yoshihiro.kawaoka@wisc.eduImaiMasakihttps://orcid.org/0000-0001-6988-19751mimai@ims.u-tokyo.ac.jp[1], Division of VirologyDepartment of"/>
  <result pre="cited.file:IRV-14-311.pdf Abstract Abstract Background Here, we genetically and antigenically analyzed" exact="influenza" post="B viruses (IBVs) isolated in Japan during the 2017�?2018"/>
  <result pre="viruses (IBVs) isolated in Japan during the 2017�?2018 and 2018�?2019" exact="influenza" post="seasons. Methods A total of 68 IBVs (61 B/Yamagata/16/88�?like"/>
  <result pre="and the variant with reduced NA inhibitor susceptibility. antigenicity hemagglutinin" exact="influenza" post="B virus Japan neuraminidase inhibitors Funding Leading Advanced Projects"/>
  <result pre="page-count: word-count: Kato�?MiyashitaS, Sakai�?TagawaY, YamashitaM, et al. Antigenic variants of" exact="influenza" post="B viruses isolated in Japan during the 2017�?2018 and"/>
  <result pre="B viruses isolated in Japan during the 2017�?2018 and 2018�?2019" exact="influenza" post="seasons. Influenza Other Respi Viruses. 2020;14:311–319. 10.1111/irv.12713 The peer"/>
  <result pre="available at https://publons.com/publon/10.1111/irv.12713 1 INTRODUCTION Influenza is an acute respiratory" exact="infectious disease" post="caused by influenza A and B viruses. Currently, two"/>
  <result pre="INTRODUCTION Influenza is an acute respiratory infectious disease caused by" exact="influenza" post="A and B viruses. Currently, two subtypes of influenza"/>
  <result pre="by influenza A and B viruses. Currently, two subtypes of" exact="influenza" post="A viruses (A/H1N1 and A/H3N2) and two lineages of"/>
  <result pre="influenza A viruses (A/H1N1 and A/H3N2) and two lineages of" exact="influenza" post="B viruses (B/Victoria/2/87�?like [B/Victoria]�? and B/Yamagata/16/88�?like [B/Yamagata]�?lineage) are cocirculating"/>
  <result pre="of adults and 20%�?30% of children are infected with seasonal" exact="influenza" post="viruses, causing 3�?5 million cases of severe illness,1 and"/>
  <result pre="and an estimated 290 000�?650 000 influenza�?related deaths.2 Therefore, seasonal" exact="influenza" post="is associated with significant morbidity and mortality worldwide. The"/>
  <result pre="influenza is associated with significant morbidity and mortality worldwide. The" exact="influenza" post="A and B viruses possess two surface glycoproteins, hemagglutinin"/>
  <result pre="to the emergence of drug�?resistant variants.5, 6 During the 2017�?2018" exact="influenza" post="season, influenza A/H1N1 2009 pandemic (A/H1N1pdm), A/H3N2, and B"/>
  <result pre="emergence of drug�?resistant variants.5, 6 During the 2017�?2018 influenza season," exact="influenza" post="A/H1N1 2009 pandemic (A/H1N1pdm), A/H3N2, and B viruses co�?circulated"/>
  <result pre="and B viruses co�?circulated in Japan.7 Notably, in Japan, the" exact="influenza" post="B epidemic of this season was larger than that"/>
  <result pre="Here, we examined the genetic and antigenic properties of the" exact="influenza" post="B viruses isolated in Japan during the winter season."/>
  <result pre="Japan during the winter season. In addition, we characterized the" exact="influenza" post="B viruses isolated in Japan during the 2018�?2019 season,"/>
  <result pre="viruses isolated in Japan during the 2018�?2019 season, even though" exact="influenza" post="B viruses circulated at a lower level in this"/>
  <result pre="the University of Tokyo (approval no. 26�?42�?0822). Samples that were" exact="influenza" post="B�?positive by real�?time RT�?PCR (see below) were used in"/>
  <result pre="the viral PB2, PB1, PA, and nucleoprotein proteins derived from" exact="influenza" post="B virus strain B/Yamagata/1/73, under the control of the"/>
  <result pre="Real�?time PCR was performed to determine the lineage of the" exact="influenza" post="B viruses in the clinical specimens. RNA was extracted"/>
  <result pre="with primers specific for the HA or NA genes of" exact="influenza" post="B virus. The PCR products were purified and directly"/>
  <result pre="2.7 Phylogenic analysis Nucleotide sequences of the HA genes of" exact="influenza" post="B viruses were aligned using mega version 7.0.26.13 The"/>
  <result pre="Health Protection Agency, London, UK.16 3 RESULTS 3.1 Detection of" exact="influenza" post="B viruses in Japan during the 2017�?2018 and 2018�?2019"/>
  <result pre="illness in Tokyo, Japan, and 108 were confirmed to be" exact="influenza" post="B virus�?positive by real�?time RT�?PCR using lineage�?specific primers/probes. Of"/>
  <result pre="B virus�?positive by real�?time RT�?PCR using lineage�?specific primers/probes. Of 97" exact="influenza" post="B virus�?positive samples collected during the 2017�?2018 season, 95"/>
  <result pre="with the National Institute of Infectious Diseases (NIID) report that" exact="influenza" post="B viruses of the B/Yamagata�? and B/Victoria�?lineages co�?circulated in"/>
  <result pre="during the winter season with the B/Yamagata�?lineage predominating.7 Of 11" exact="influenza" post="B virus�?positive samples collected during the 2018�?2019 season, two"/>
  <result pre="the B/Yamagata�?linage and nine were of the B/Victoria�?lineage. All 108" exact="influenza" post="B viruses were isolated from the clinical samples by"/>
  <result pre="inoculation to MDCK, AX4, or hCK cells. Of the 108" exact="influenza" post="B isolates, 68 (62 from the 2017�?2018 season and"/>
  <result pre="selected for further characterization. 3.2 Antigenic and genetic characterization of" exact="influenza" post="B viruses isolated in Japan during the 2017�?2018 and"/>
  <result pre="B/Brisbane/60/2008. To determine the HA gene clade of the 68" exact="influenza" post="B viruses isolated in Japan during the 2017�?2018 and"/>
  <result pre="Data (GISAID) EpiFlu database. Since the 2015�?2016 season, only quadrivalent" exact="influenza" post="vaccines containing two influenza A virus strains (A/H1N1pdm and"/>
  <result pre="Since the 2015�?2016 season, only quadrivalent influenza vaccines containing two" exact="influenza" post="A virus strains (A/H1N1pdm and A/H3N2) and two influenza"/>
  <result pre="two influenza A virus strains (A/H1N1pdm and A/H3N2) and two" exact="influenza" post="B virus strains (B/Yamagata�?lineage and B/Victoria�?lineage viruses) have been"/>
  <result pre="B/Victoria�?lineage viruses isolated in Japan during the 2017�?2018 and 2018�?2019" exact="influenza" post="seasons. The tree was built using the neighbor�?joining method"/>
  <result pre="deletion at positions 162�?164 in HA, respectively To elucidate whether" exact="influenza" post="B viruses isolated in Japan during the 2017�?2018 and"/>
  <result pre="B viruses isolated in Japan during the 2017�?2018 and 2018�?2019" exact="influenza" post="seasons were antigenically related to the vaccine strains used"/>
  <result pre="Sons, Ltd, 3.3 Antiviral susceptibility To monitor the susceptibility of" exact="influenza" post="B viruses to NA inhibitors in Japan during the"/>
  <result pre="mutations known to confer resistance to NA inhibitors in the" exact="influenza" post="B isolates, except for one B/Yamagata�?lineage isolate (B/Tokyo/UT�?AC032/2018) that"/>
  <result pre="the B/Victoria�?lineage viruses that were detected worldwide during the eight" exact="influenza" post="seasons that followed the 2009�?2010 season were antigenically closely"/>
  <result pre="virus with the two�?amino�?acid deletion for the 2019�?2020 northern hemisphere" exact="influenza" post="vaccine.18 Our antigenic analyses with post�?infection ferret sera showed"/>
  <result pre="the 2015�?2016 season.23 In this study, we also detected an" exact="influenza" post="B virus with the NA�?G407S mutation during the 2017�?2018"/>
  <result pre="it is unclear whether the patient had contact with an" exact="influenza" post="patient who was treated with NA inhibitors, it is"/>
  <result pre="to determine whether this NA�?G407S mutation affects the transmissibility of" exact="influenza" post="B viruses. This virological surveillance study may have been"/>
  <result pre="area in Japan and by the relatively small number of" exact="influenza" post="B isolates. Nevertheless, such monitoring of the most recent"/>
  <result pre="Initiative on Sharing Avian Influenza Data (GISAID) for sharing the" exact="influenza" post="virus sequence data used in this study. We also"/>
  <result pre="Lancet. 2018;391:1285�?1300.29248255 3HayAJ, GregoryV, DouglasAR, YiPL. The evolution of human" exact="influenza" post="viruses. Philos Trans R Soc B Biol Sci. 2001;356:1861�?1870."/>
  <result pre="antigenic drift. Vaccine. 2007;25:6852�?6862.17719149 5BurnhamAJ, BaranovichT, GovorkovaEA. Neuraminidase inhibitors for" exact="influenza" post="B virus infection: efficacy and resistance. Antiviral Res. 2013;100:520�?534.24013000"/>
  <result pre="α2,6�?linked sialic acid on MDCK cells improves isolation of human" exact="influenza" post="viruses and evaluation of their sensitivity to a neuraminidase"/>
  <result pre="cell line for the efficient isolation and propagation of human" exact="influenza" post="viruses. Nat Microbiol. 2019;4(8):1268�?1273.31036910 10NeumannG, WatanabeT, ItoH, et al."/>
  <result pre="Nat Microbiol. 2019;4(8):1268�?1273.31036910 10NeumannG, WatanabeT, ItoH, et al. Generation of" exact="influenza" post="A viruses entirely from cloned cDNAs. Proc Natl Acad"/>
  <result pre="copy number). Gene. 1991;108:193�?199.1660837 12ZhouB, LinX, WangW, et al. Universal" exact="influenza" post="B virus genomic amplification facilitates sequencing, diagnostics, and reverse"/>
  <result pre="2016;33:1870�?1874.27004904 14KisoM, Iwatsuki�?HorimotoK, YamayoshiS, et al. Emergence of oseltamivir�?resistant H7N9" exact="influenza" post="viruses in immunosuppressed cynomolgus macaques. J Infect Dis. 2017;216:582�?593.28931216"/>
  <result pre="Infect Dis. 2017;216:582�?593.28931216 15HatakeyamaS, SugayaN, ItoM, et al. Emergence of" exact="influenza" post="B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA."/>
  <result pre="2019. 19collab: WHO . WHO recommendations on the composition of" exact="influenza" post="virus vaccines. https://www.who.int/influenza/vaccines/virus/recommendations/en/. Accessed 3 June 2019. 20BlantonL, AlabiN,"/>
  <result pre="Accessed 3 June 2019. 20BlantonL, AlabiN, MustaquimD, et al. Update:" exact="influenza" post="activity in the United States during the 2016–17 season"/>
  <result pre="States during the 2016–17 season and composition of the 2017–18" exact="influenza" post="vaccine. MMWR Morb Mortal Wkly Rep. 2017;66:668�?676.28662019 21collab: WHO"/>
  <result pre="Accessed 27 May 2019. 22collab: WHO . Recommended composition of" exact="influenza" post="virus vaccines for use in the 2019 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2019 southern hemisphere" exact="influenza" post="season. https://www.who.int/influenza/vaccines/virus/recommendations/201809_recommendation.pdf. Accessed 3 June 2019. 23GubarevaLV, BesselaarTG, DanielsRS,"/>
  <result pre="DanielsRS, et al. Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2015–2016. Antiviral Res. 2017;146:12�?20.28802866"/>
 </snippets>
</snippetsTree>
